Showing 1,981 - 2,000 results of 18,038 for search 'significantly ((((((we decrease) OR (largest decrease))) OR (teer decrease))) OR (a decrease))', query time: 0.56s Refine Results
  1. 1981
  2. 1982
  3. 1983
  4. 1984

    Table 1_DYRK1A roles in human neural progenitors.xlsx by Jeremie Courraud (20871932)

    Published 2025
    “…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”
  5. 1985

    Data Sheet 1_DYRK1A roles in human neural progenitors.docx by Jeremie Courraud (20871932)

    Published 2025
    “…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”
  6. 1986
  7. 1987

    S1 Data - by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  8. 1988

    Characteristics of AMI patients with DM. by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  9. 1989

    Four grid table. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  10. 1990

    Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  11. 1991

    Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  12. 1992

    Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  13. 1993
  14. 1994
  15. 1995
  16. 1996
  17. 1997

    S1 Data - by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  18. 1998

    Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  19. 1999
  20. 2000